TVGN

Tevogen Bio Holdings (TVGN)

About Tevogen Bio Holdings (TVGN)

Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. It focuses on its product, ExacTcell, a technology that treats acute viral infections, long-term consequences of viral infections, and viral and non-viral induced cancers. The company was founded in April 2021 and is headquartered in Warren, NJ.

Details

Daily high
$0.29
Daily low
$0.27
Price at open
$0.28
52 Week High
$1.69
52 Week Low
$0.25
Market cap
56.4M
Dividend yield
0.00%
Volume
497,935
Avg. volume
826,213
P/E ratio
-1.58

Tevogen Bio Holdings News

Details

Daily high
$0.29
Daily low
$0.27
Price at open
$0.28
52 Week High
$1.69
52 Week Low
$0.25
Market cap
56.4M
Dividend yield
0.00%
Volume
497,935
Avg. volume
826,213
P/E ratio
-1.58